Eva Maria Galan-Moya

19PUBLICATIONS
55CO-AUTHORS
Molecular targetsHorticultural crop improvement (incl. selection and breeding)Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples life coursePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 11, 2026
Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies.

Daniel Ortega-Álvarez, David Tébar-García, Marta Casado-Peláez

|Jan 28, 2026
Rosa x hybrida: A New Tool for Functional Food Development with Triple-Negative Breast Antitumoral Implications.

Lorenzo Rivas-Garcia, Tamara Y Forbes-Hernández, Pablo Cristóbal-Cueto

|Aug 06, 2025
Palladium Complex-Supported Silica Nanocarriers: Enhancing Therapeutic Efficacy and Reducing Curcumin Toxicity in Breast Cancer.

Lorenzo Rivas-García, José Manuel Méndez-Arriaga, Sandra Jiménez-Falcao

|Oct 28, 2023
TACkling Cancer by Targeting Selective Protein Degradation.

María Del Mar Noblejas-López, David Tébar-García, Raquel López-Rosa

|Sep 07, 2023
Adaptation and validation of the PAC-19QoL-specific quality of life questionnaire for the Spanish population with long COVID.

Irene Marcilla-Toribio, Maria Martinez-Andres, Maria Leopolda Moratalla-Cebrian

|May 28, 2022
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.

María Del Mar Noblejas-López, Lucía Gandullo-Sánchez, Eva M Galán-Moya

Pageof 4

Frequent Collaborators

7 joint publications

Alberto Ocana

3 joint publications

María Del Mar Noblejas-López

3 joint publications

David Tébar-García

2 joint publications

Jose Manuel Perez-Ortiz